DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
SAN DIEGO--(BUSINESS WIRE)--Jun 26, 2026-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re- …